Sarfaraz Ahmad Ejazi

Sarfaraz Ahmad Ejazi

Auto-generated profile, based on publicly available information

Sarfaraz Ahmad Ejazi

Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, 700032, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SDSonali Das
Sonali Das
ABAnindyajit Banerjee
Anindyajit Banerjee
MKMohd. Kamran
Mohd. Kamran
SESarfaraz Ahmad Ejazi
Sarfaraz Ahmad Ejazi
MAMohammad Asad
Mohammad Asad
SCSaikat Chakrabarti
Saikat Chakrabarti
Emergence of resistance to available anti-leishmanial drugs advocates identification of new drug targets and their inhibitors for visceral leishmaniasis. Here, we identified heat shock protein 78 in Leishmania donovani (LdHSP78), a putative ClpB protease, as important for parasite infection of host macrophages and a potential therapeutic target. Enrichment of LdHSP78 in infected humans, hamsters and parasite amastigotes suggested its importance for disease persistence. Heterozygous knockouts of L. donovani (LdHSP78+/-) and L. mexicana (LmxHSP78+/-) were generated using flanking untranslated region (UTR) based multi-fragment ligation strategy and CRISPR-Cas9 technique, respectively to investigate the significance of HSP78 for disease manifestation. LdHSP78+/- parasite burden was dramatically reduced in both murine bone marrow–derived macrophages and hamsters, associated with enrichment of pro-inflammatory cytokines and nitric oxide (NO). This finding implies that LdHSP78+/- parasites cannot suppress immune activation and escape NO-mediated toxicity in macrophages. Further, phosphorylation of the mitogen-activated protein kinase (MAPK) p38 was enhanced, and phosphorylation of extracellular signal–regulated kinase 1/2 (ERK1/2) was decreased in cells infected with LdHSP78+/- compared to wildtype (WT) infection. Virulence of the LdHSP78+/- strain was restored by episomal addition of LdHSP78 gene. Finally, using high-throughput virtual screening, we identified P1,P5-di(adenosine-5’)-penta-phosphate ammonium salt (Ap5A) as an LdHSP78 inhibitor. It selectively induced amastigote death at doses similar to amphotericin B (AmB) dosing, while exhibiting much less cytotoxicity toward healthy macrophages than AmB. In summary, using both a genetic knockout approach and pharmacological inhibition, we establish LdHSP78 as a drug target and Ap5A as a potential lead for improved anti-leishmanial agents.

14 May 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MKMohd Kamran
Mohd Kamran
SESarfaraz Ahmad Ejazi
Sarfaraz Ahmad Ejazi
SCSomsubhra Thakur Choudhury
Somsubhra Thakur Choudhury
ABAnirban Bhattacharyya
Anirban Bhattacharyya
KTKm Tanishka
Km Tanishka
Nahid AliNahid Ali
Nahid Ali
Tests for visceral leishmaniasis (VL) are not uniformly effective for all endemic regions. In a serological assay, a novel antigen, otubain cysteine peptidase, compared with rK39, showed comparable sensitivity with Indian VL serum samples and prominently increased sensitivity with Brazilian samples, as well as improved monitoring of the treatment response.

9 July 2025 in Biochemical Journal
Verified
Journal Article
Open access
JBJames A. Brannigan
James A. Brannigan
MKMohd Kamran
Mohd Kamran
NJNathaniel G. Jones
Nathaniel G. Jones
ENElisa M. Nightingale
Elisa M. Nightingale
EDEleanor J. Dodson
Eleanor J. Dodson
AWAnthony Wilkinson
Anthony Wilkinson
In Leishmania parasites, as for their hosts, the ubiquitin (Ub) proteasome system is important for cell viability. As part of a systematic gene deletion study, it was discovered that four cysteine protease-type deubiquitinases (DUBs) are essential for parasite survival in the promastigote stage, including DUB16. Here, we have purified and characterised recombinant DUB16 from Leishmania donovani, which belongs to the Ub C-terminal hydrolase (UCH) family. DUB16 efficiently hydrolyses C-terminal aminocoumarin and rhodamine conjugates of Ub consistent with proposed cellular roles of UCH-type DUBs in regenerating free monomeric Ub from small molecule Ub adducts arising from adventitious metabolic processes. The crystal structure of DUB16 reveals a typical UCH-type DUB fold, and a relatively short and disordered cross-over loop that appears to restrict access to the catalytic cysteine. At close to stoichiometric enzyme to substrate ratios, DUB16 exhibits DUB activity towards diubiquitins linked through isopeptide bonds between Lys11, Lys48 or Lys63 residues of the proximal Ub and the C-terminus of the distal Ub. With 100–1000-fold higher turnover rates, DUB16 cleaves the ubiquitin–ribosomal L40 fusion protein to give the mature products. A DUB-targeting cysteine-reactive cyanopyrrolidine compound, IMP-1710, inhibits DUB16 activity. IMP-1710 was shown in promastigote cell viability assays to have parasite killing activity with EC50 values of 1–2 μM, comparable with the anti-leishmanial drug, miltefosine. L. mexicana parasites engineered to overproduce DUB16 showed a modest increase in resistance to IMP-1710, providing evidence that IMP-1710 inhibits DUB16 in vivo. While it is highly likely that IMP-1710 has additional targets, these results suggest that DUB16 is a potential target for the development of new anti-leishmanial compounds.

1 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJames A. Brannigan
James A. Brannigan
MKMohd Kamran
Mohd Kamran
NJNathaniel G. Jones
Nathaniel G. Jones
ENElisa M. Nightingale
Elisa M. Nightingale
EDEleanor J. Dodson
Eleanor J. Dodson
AWAnthony Wilkinson
Anthony Wilkinson
In Leishmania parasites, as for their hosts, the ubiquitin proteasome system is important for cell viability. As part of a systematic gene deletion study, it was discovered that four cysteine protease type deubiquitinases (DUBs) are essential for parasite survival in the promastigote stage, including DUB16. Here we have purified and characterised recombinant DUB16 from Leishmania donovani , which belongs to the ubiquitin C-terminal hydrolase (UCH) family. DUB16 efficiently hydrolyses C-terminal aminocoumarin and rhodamine conjugates of ubiquitin consistent with proposed cellular roles of UCH-type DUBs in regenerating free monomeric ubiquitin from small molecule ubiquitin adducts arising from adventitious metabolic processes. The crystal structure of DUB16 reveals a typical UCH-type deubiquitinase fold, and a relatively short and disordered crossover loop that appears to restrict access to the catalytic cysteine. At close to stoichiometric enzyme to substrate ratios, DUB16 exhibits deubiquitinase activity towards diubiquitins linked through isopeptide bonds between Lys11, Lys48 or Lys63 residues of the proximal ubiquitin and the C-terminus of the distal ubiquitin. With 100-1000-fold higher turnover rates, DUB16 cleaves the ubiquitin-ribosomal L40 fusion protein to give the mature products. A DUB-targeting cysteine-reactive cyanopyrrolidine compound, IMP-1710, inhibits DUB16 activity. IMP-1710 was shown in promastigote cell viability assays to have parasite killing activity with EC 50 values of 1−2 μM, comparable to the anti-leishmanial drug, miltefosine. L. mexicana parasites engineered to overproduce DUB16 showed a modest increase in resistance to IMP-1710, providing evidence that IMP-1710 inhibits DUB16 in vivo . Together these results suggest on-target activity and that DUB16 may be a druggable target to develop new anti-leishmania compounds.

1 January 2026 in International Journal of Microbiology
Verified
Journal Article
Open access
THThashmila Heshani
Thashmila Heshani
DSDilshan Sandaru
Dilshan Sandaru
SMSachindu Madhushara
Sachindu Madhushara
SESarfaraz Ahmad Ejazi
Sarfaraz Ahmad Ejazi
BDBhagya Deepachandi
Bhagya Deepachandi
Meningitis, an acute and life‐threatening inflammation of the protective membranes covering the brain and spinal cord caused primarily by bacterial, viral, fungal, or parasitic infections, remains a major global health challenge, causing significant morbidity and mortality, particularly among children and vulnerable populations. The Sri Lankan epidemiological unit reported approximately 1000–1500 meningitis cases annually. This review summarizes current knowledge on meningitis in Sri Lanka, drawing on global evidence and locally published studies to examine epidemiology, clinical presentation, diagnostic approaches, immunity gap, and future priorities. Most studies indicate that bacterial meningitis, particularly caused by Streptococcus pneumoniae , Neisseria meningitidis , and Haemophilus influenzae , remains the most severe and clinically significant form. Viral etiologies, especially enteroviruses, are also commonly reported. Although the introduction of the H. influenzae Type b (Hib) vaccine has significantly reduced disease burden, important immunity gaps persist due to limited pneumococcus serotype coverage and the absence of routine meningococcal vaccination. Diagnostic challenges, including delays in cerebrospinal fluid collection, limited access to molecular testing, and preanalytical errors, hinder early detection and accurate pathogen identification. Future directions should focus on strengthening molecular diagnostic capacity, strengthening point‐of‐care rapid antigen assays and decentralized molecular diagnostics, expanding serotype surveillance, improving sample collection practices, and evaluating the feasibility of introducing meningococcal vaccination into the national immunization schedule. Bridging these gaps is essential for aligning Sri Lanka′s efforts with global targets outlined in the World Health Organization′s (WHO) Defeating Meningitis by 2030 roadmap.

7 December 2023
Verified
Preprint
Open access
PDF file
SESarfaraz Ahmad Ejazi
Sarfaraz Ahmad Ejazi
This study investigates the prevalence of the Buruli ulcer disease in the Jasikan municipality of Ghana. This information collected in this study might be helpful in planning and policymaking. Besides, below are my suggestions. * Adding the country...